Abstract:P62 can recognize and bind ubiquitin‐modified NLRP3. It plays a vital role in regulating the inflammatory response by participating in the ALP‐associated NLRP3 protein degradation, which improves cognitive function in AD by reducing pro‐inflammatory status and pyroptosis of microglia, thus maintaining its phagocytosis function. Background Activation of the NLRP3 inflammasome promotes microglia to secrete inflammatory cytokines and induce pyroptosis, leading to impaired phagocytic and clearance functions of microglia in Alzheimer's disease (AD). This study found that the autophagy‐associated protein p62 interacts with NLRP3, which is the rate‐limiting protein of the NLRP3 inflammasome. Thus, we aimed to prove that the degradation of NLRP3 occurs through the autophagy‐lysosome pathway (ALP) and also demonstrate its effects on the function of microglia and pathological changes in AD. Methods The 5XFAD/NLRP3‐KO mouse model was established to study the effect of NLRP3 reduction on AD. Behavioral experiments were conducted to assess the cognitive function of the mice. In addition, immunohistochemistry was used to evaluate the deposition of Aβ plaques and morphological changes in microglia. BV2 cells treated with lipopolysaccharide (LPS) followed by Aβ1‐42 oligomers were used as in vitro AD inflammation models and transfected with lentivirus to regulate the expression of the target protein. The pro‐inflammatory status and function of BV2 cells were detected by flow cytometry and immunofluorescence (IF). Co‐immunoprecipitation, mass spectrometry, IF, Western blot (WB), quantitative real‐time PCR, and RNA‐seq analysis were used to elucidate the mechanisms of molecular regulation. Results Cognitive function was improved in the 5XFAD/NLRP3‐KO mouse model by reducing the pro‐inflammatory response of microglia and maintaining the phagocytic and clearance function of microglia to the deposited Aβ plaque. The pro‐inflammatory function and pyroptosis of microglia were regulated by NLRP3 expression. Ubiquitinated NLRP3 can be recognized by p62 and degraded by ALP, slowing down the proinflammatory function and pyroptosis of microglia. The expression of autophagy pathway‐related proteins such as LC3B/A, p62 was increased in the AD model in vitro. Conclusions P62 recognizes and binds to ubiquitin‐modified NLRP3. It plays a vital role in regulating the inflammatory response by participating in ALP‐associated NLRP3 protein degradation, which improves cognitive function in AD by reducing the pro‐inflammatory status and pyroptosis of microglia, thus maintaining its phagocytic function.

Beclin1‐driven autophagy modulates the inflammatory response of microglia via NLRP 3

Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.

Enhanced Autolysosomal Function Ameliorates the Inflammatory Response Mediated by the NLRP3 Inflammasome in Alzheimer’s Disease

Targeting microglial autophagic degradation in NLRP3 inflammasome-mediated neurodegenerative diseases

Interaction between autophagy and the NLRP3 inflammasome in Alzheimer's and Parkinson's disease

The NLRP3-Caspase 1 Inflammasome Negatively Regulates Autophagy via TLR4-TRIF in Prion Peptide-Infected Microglia

Mechanisms of NLRP3 Inflammasome Activation: Its Role in the Treatment of Alzheimer’s Disease

Microglial autophagy‐mediated clearance of amyloid‐beta plaques is dysfunctional in Alzheimer’s disease mice

Degradation of NLRP3 by p62‐dependent‐autophagy improves cognitive function in Alzheimer's disease by maintaining the phagocytic function of microglia

Activation of the NLRP3 inflammasome in microglia: the role of ceramide

Deficient chaperone-mediated autophagy facilitates LPS-induced microglial activation via regulation of the p300/NF-κB/NLRP3 pathway

The Role of the Effects of Autophagy on NLRP3 Inflammasome in Inflammatory Nervous System Diseases

Autophagy enables microglia to engage amyloid plaques and prevents microglial senescence

The aging mouse CNS is protected by an autophagy-dependent microglia population promoted by IL-34

GM1 modulates amyloid‐beta activation of NLRP3 inflammasome in microglia through Akt/mTOR‐mediated regulation of autophagy

Microglial autophagy defect causes parkinson disease-like symptoms by accelerating inflammasome activation in mice

Microglial PD‐1 stimulation by astrocytic PD‐L1 suppresses neuroinflammation and Alzheimer’s disease pathology

Glutamine metabolism modulates microglial NLRP3 inflammasome activity through mitophagy in Alzheimer's disease

Arginase 1+ microglia reduce Aβ plaque deposition during IL-1β-dependent neuroinflammation

Role Of Pro-Inflammatory Cytokines Released From Microglia In Alzheimer'S Disease

NLRP3 inflammasome activation drives tau pathology